Pharmacokinetics of indinavir and nelfinavir in treatment-naive, human immunodeficiency virus-infected subjects
about
Pharmacokinetics of nelfinavir and efavirenz in antiretroviral-naive, human immunodeficiency virus-infected subjects when administered alone or in combination with nucleoside analog reverse transcriptase inhibitors.Population pharmacokinetic analysis for nelfinavir and its metabolite M8 in virologically controlled HIV-infected patients on HAART.A review of nelfinavir for the treatment of HIV infection.
P2860
Pharmacokinetics of indinavir and nelfinavir in treatment-naive, human immunodeficiency virus-infected subjects
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Pharmacokinetics of indinavir ...... ciency virus-infected subjects
@ast
Pharmacokinetics of indinavir ...... ciency virus-infected subjects
@en
type
label
Pharmacokinetics of indinavir ...... ciency virus-infected subjects
@ast
Pharmacokinetics of indinavir ...... ciency virus-infected subjects
@en
prefLabel
Pharmacokinetics of indinavir ...... ciency virus-infected subjects
@ast
Pharmacokinetics of indinavir ...... ciency virus-infected subjects
@en
P2093
P2860
P1476
Pharmacokinetics of indinavir ...... ciency virus-infected subjects
@en
P2093
AIDS Clinical Trials Group 388/733/5060 Study Team
Alan Forrest
Ann Collier
Gene D Morse
Heather Ribaudo
Judith Feinberg
Margaret A Fischl
Robert DiCenzo
Robin DiFrancecso
P2860
P304
P356
10.1128/AAC.48.3.918-923.2004
P407
P577
2004-03-01T00:00:00Z